SC
PRTK

Scholtz & Company’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Scholtz & Company’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-16,195
Closed -$88K – 82
2020
Q3 		$88K Sell
16,195
-7,300
-31% -$39.7K 0.04% 68
2020
Q2 		$123K Buy
+23,495
New +$123K 0.06% 59